|
DPF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.873800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.576200E-01 |
| Normal-vs-Stage2 |
5.525000E-01 |
| Normal-vs-Stage3 |
3.034000E-01 |
| Normal-vs-Stage4 |
8.887200E-01 |
| Stage1-vs-Stage2 |
2.856600E-01 |
| Stage1-vs-Stage3 |
8.307700E-02 |
| Stage1-vs-Stage4 |
8.146400E-01 |
| Stage2-vs-Stage3 |
7.138200E-01 |
| Stage2-vs-Stage4 |
6.031400E-01 |
| Stage3-vs-Stage4 |
4.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.308600E-01 |
| Normal-vs-AfricanAmerican |
5.246000E-01 |
| Normal-vs-Asian |
8.033800E-01 |
| Caucasian-vs-AfricanAmerican |
3.043000E-01 |
| Caucasian-vs-Asian |
6.860400E-01 |
| AfricanAmerican-vs-Asian |
9.596000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.524000E-01 |
| Normal-vs-Female |
6.787800E-02 |
| Male-vs-Female |
3.935400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.400800E-01 |
| Normal-vs-Extreme_Weight |
2.472600E-01 |
| Normal-vs-Obese |
3.178600E-01 |
| Normal-vs-Extreme_Obese |
5.551500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.489600E-01 |
| Normal_Weight-vs-Obese |
5.279600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.713200E-01 |
| Extreme_Weight-vs-Obese |
3.700100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.167800E-01 |
| Obese-vs-Extreme_Obese |
5.268400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.814400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.947400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.306800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.056400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.466750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.041900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.569650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.858100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.494000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.015400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.363400E-01 |
| Normal-VS-Type2 PRCC |
9.045500E-02 |
| Normal-VS-KIRP CIMP |
8.563300E-04 |
| Normal-VS-Unclassified PRCC |
4.609800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.032300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.060800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.650800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.413200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.705900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.159800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.518790E-01 |
| Normal-vs-N1 |
8.414300E-02 |
| Normal-vs-N2 |
8.692600E-01 |
| N0-vs-N1 |
1.204140E-02 |
| N0-vs-N2 |
4.585200E-01 |
| N1-vs-N2 |
5.096200E-01 |
|
|
